Pelayo Nieto-Gómez

7PUBLICATIONS
3CO-AUTHORS
Molecular targetsPharmacogenomicsData and information privacyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
Factors influencing the reimbursement decisions of cancer drugs in Spanish National Health System.

|May 23, 2026
Influence of clinical benefit and cost-effectiveness on reimbursement decisions for lung cancer drugs in Spain.

|Jun 03, 2025
Misalignment between patient preferences and clinician expectations: Do press releases make clinicians impatient to the detriment of patients?

Pelayo Nieto-Gómez, Celia Castaño-Amores

|Aug 06, 2024
Reevaluating immunotherapy's potential in first-line metastatic urothelial carcinoma.

Celia Castaño-Amores, Pelayo Nieto-Gómez

|Jul 03, 2024
Factors influencing the reimbursement of cancer drugs in Europe: A scoping review.

Pelayo Nieto-Gómez, Celia Castaño-Amores

|Sep 14, 2023
Letter to the Editor Regarding: "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis".

Pelayo Nieto-Gómez, Celia Castaño-Amores

Pageof 2

Frequent Collaborators

6 joint publications

Celia Castaño-Amores

2 joint publications

Antonio José García-Ruiz

2 joint publications

Juan Oliva-Moreno